TF
CVS icon

TIAA FSB’s CVS Health CVS Stock Holding History

TIAA FSB’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3.1M Sell
44,805
-3,306
-7% -$235K 0.01% 228
2023
Q1 		$3.58M Sell
48,111
-9,642
-17% -$809K 0.01% 217
2022
Q4 		$5.38M Buy
57,753
+5,630
+11% +$543K 0.02% 199
2022
Q3 		$4.97M Buy
52,123
+802
+2% +$79.4K 0.02% 194
2022
Q2 		$4.75M Sell
51,321
-3,985
-7% -$389K 0.02% 192
2022
Q1 		$5.55M Buy
55,306
+774
+1% +$81.3K 0.02% 191
2021
Q4 		$5.58M Sell
54,532
-602
-1% -$55.6K 0.02% 191
2021
Q3 		$4.68M Sell
55,134
-1,450
-3% -$121K 0.02% 197
2021
Q2 		$4.72M Buy
56,584
+41
+0.1% +$3.36K 0.02% 200
2021
Q1 		$4.25M Sell
56,543
-2,366
-4% -$172K 0.02% 201
2020
Q4 		$4.02M Buy
58,909
+3,101
+6% +$202K 0.02% 195
2020
Q3 		$3.26M Sell
55,808
-5,387
-9% -$335K 0.01% 194
2020
Q2 		$3.98M Sell
61,195
-1,101
-2% -$69.3K 0.02% 187
2020
Q1 		$3.7M Sell
62,296
-1,295
-2% -$86.5K 0.02% 178
2019
Q4 		$4.72M Buy
63,591
+232
+0.4% +$16.3K 0.02% 190
2019
Q3 		$4M Sell
63,359
-20,031
-24% -$1.19M 0.02% 188
2019
Q2 		$4.54M Sell
83,390
-297,149
-78% -$16M 0.03% 170
2019
Q1 		$20.5M Buy
380,539
+79,096
+26% +$4.88M 0.16% 73
2018
Q4 		$19.8M Buy
301,443
+79,754
+36% +$5.95M 0.11% 68
2018
Q3 		$17.5M Buy
221,689
+158,413
+250% +$11.3M 0.09% 80
2018
Q2 		$4.07M Sell
63,276
-3,207
-5% -$211K 0.02% 173
2018
Q1 		$4.14M Sell
66,483
-3,728
-5% -$267K 0.02% 168
2017
Q4 		$5.09M Sell
70,211
-15,305
-18% -$1.11M 0.03% 155
2017
Q3 		$6.95M Sell
85,516
-58,975
-41% -$4.67M 0.04% 132
2017
Q2 		$11.6M Buy
+144,491
New +$11.4M 0.08% 90

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

TIAA FSB's CVS Position: Q2 2023 in Review

TIAA FSB reduced its CVS Health (CVS) stake by 6.9% in Q2 2023, selling an estimated $235K and leaving 44,805 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #228.

TIAA FSB first reported a position in CVS in Q2 2017 and has held it in 25 quarters since. The position peaked at $20.5M in Q1 2019. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • TIAA FSB held 44,805 shares of CVS Health worth $3.1M as of Q2 2023.
  • TIAA FSB sold 3,306 CVS Health shares in Q2 2023, an estimated $235K.
  • CVS Health made up 0.01% of TIAA FSB's portfolio in Q2 2023, its #228 holding.
  • TIAA FSB first reported a position in CVS Health in Q2 2017 and has held it in 25 quarters since.
  • TIAA FSB's CVS Health position peaked at $20.5M in Q1 2019.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.